RxDoctor Payments Data

Jason Moreland, MD

Interventional Cardiology · Morgantown, WVNPI 1962612408

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (34.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Abiomed accounts for 74.2% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $4,954 and has fallen 90.0% since, to $495 in 2025.

$8,613in general payments, 2019–2025

Across 75 payments — averaging $114.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abiomed$6K
  • Medtronic$1K
  • Shockwave Medical, Inc$249
  • Boston Scientific$156
  • Stryker$122
  • Asahi Intecc USA, Inc.$120
  • plus $282 from 6 others
$8,525in research payments, 2019–2025

Across 11 payments — averaging $774.98 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$7K
  • Abiomed$1K

What the payments were for

  • Speaking & faculty fees$3,00035%
  • Travel & lodging$2,71331%
  • Food & beverage$2,90134%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,613 in reported general payments places this provider in the 55th percentile of 46 interventional cardiology providers in West Virginia.

See all interventional cardiology providers in West Virginia

Medicare billing

Part B allowed, 2024
$61,195
Medicare patients
289
Services billed
529

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Atorvastatin Calcium39$609
Rosuvastatin Calcium22$381
Pravastatin Sodium16$368
Metoprolol Succinate29$359
Furosemide50$330
Valsartan15$224
Diltiazem 24hr Er (Cd)Diltiazem Hcl12$164
ClopidogrelClopidogrel Bisulfate30$160
Isosorbide Mononitrate ErIsosorbide Mononitrate16$135
Metoprolol Tartrate16$105
Hydrochlorothiazide19$78
Lisinopril11$72

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Morgantown

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →